PBLA (PBLA) Stock Price & Analysis
PBLA (PBLA) rose 0.00% to USD 0 as of September 8, 2026 at 06:58 UTC, according to Nexqual real-time market data.
PBLA last closed at USD 0; the session ranged USD 0.02–0.02 on volume of 1,012 shares. Market capitalization is —, with a 52-week range of USD 0–2.5 (PNK). Source: Nexqual, September 8, 2026 at 06:58 UTC.
Key Statistics (as of September 8, 2026 at 06:58 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0.02 – 0.02 |
| 52-Week Range | USD 0 – 2.5 |
| Volume | 1,012 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (PBLA)
Nexqual's technical model rates PBLA "SELL" based on 2 bullish and 5 bearish signals across 129 daily candles, as of September 8, 2026 at 06:58 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 0.01) |
| MACD | -0 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PXMD | PaxMedica, Inc. | USD 0 | ▼ 28.57% |
| NEXI | NexImmune, Inc. | USD 0 | ▲ 0% |
| ZVSA | ZyVersa Therapeutics, Inc. | USD 0.1 | ▲ 4.04% |
| DRMA | Dermata Therapeutics, Inc. | USD 1.21 | ▼ 5.47% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.46 | ▲ 2.93% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:58 UTC. This page is informational and not investment advice.